Jason Hoffman, PharmD, RPh

Pregnancy around the time of, or after, diagnosis of breast cancer is not associated with an increased risk of death.

Despite the known benefits of physical activity for breast cancer survivors, a large proportion of this population continues to be physically inactive after treatment.

Zoledronic acid and clodranate are the recommended bisphosphonates for the adjuvant treatment of postmenopausal patients with breast cancer.

ASCO endorses ACS head and neck survivorship care guideline, which supports health promotion, especially regarding tobacco cessation and dental care.

There is no association between vasectomy and the risk of overall, high-grade, or advanced-stage prostate cancer or prostate cancer-related mortality.

Patients who speak to an oncology nurse prior to their first appointment are significantly more likely to be retained for their treatment.

Rechallenge with dabrafenib plus trametinib demonstrated antitumor activity in patients who had previously progressed on BRAF inhibitor therapy.

A hematologic multidisciplinary oral chemotherapy clinic established at a community hospital identified adverse events early and reduced ED visits.

Treatment with cabozantinib was active and associated with manageable toxicities in patients with hepatocellular carcinoma.

Exercise and/or psychological interventions effectively reduce cancer-related fatigue during and after cancer treatment.